Serum procalcitonin predicting mortality in exertional heatstroke

Emergency Medicine Journal

Volumn 29, Issue 2, 2012, Pages 113-117

  Tong, Hua Sheng ^a   Liu, Yun Song ^a   Wen, Qiang ^a   Tang, You Qing ^a   Yuan, Fang Fang ^a   Su, Lei ^a  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN;

ADULT; APACHE; AREA UNDER THE CURVE; ARTICLE; CLINICAL EVALUATION; CONCURRENT INFECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; ESCHERICHIA COLI; EXERCISE; HEAT STROKE; HORMONE BLOOD LEVEL; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; SENSITIVITY ANALYSIS; STANDARD; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SURVIVOR; UNIVARIATE ANALYSIS;

ADULT; AREA UNDER CURVE; BIOLOGICAL MARKERS; BODY TEMPERATURE; CALCITONIN; CHINA; HEAT STROKE; HUMANS; MALE; PHYSICAL EXERTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; REGRESSION ANALYSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84856110065     PISSN: 14720205     EISSN: 14720213     Source Type: Journal    
DOI: 10.1136/emj.2010.107680     Document Type: Article

References (35)

1. Bouchama A, Knochel JP. Heat stroke. N Engl J Med 2002;346:1978-88.
2. Whicher J, Bienvenu J, Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem 2001;38:483-93. (Pubitemid 32846053)
3. Schneider HG, Lam QT. Procalcitonin for the clinical laboratory:a review. Pathology 2007;39:383-90.
4. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis:clinical utility and limitations. Crit Care Med 2008;36:941-52.
5. Hausfater P, Hurtado M, Pease S, et al. Is procalcitonin a marker of critical illness in heatstroke? Intensive Care Med 2008;34:1377-83.
6. Nylén ES, Al Arifi A, Becker KL, et al. Effect of classic heatstroke on serum procalcitonin. Crit Care Med 1997;25:1362-5. (Pubitemid 27347301)
7. Wexler RK. Evaluation and treatment of heat-related illnesses. Am Fam Physician 2002;65:2307-14.
8. Shapiro Y, Seidman DS. Field and clinical observations of exertional heatstroke patients. Med Sci Sports Exerc 1990;22:6-14. (Pubitemid 20053285)
9. Lee-Chiong TL Jr, Stitt JT. Heatstroke and other heat-related illnesses. The maladies of summer. Postgrad Med 1995;98:26-36.
10. Dematte JE, O'Mara K, Buescher J, et al. Near-fatal heat stroke during the 1995 heat wave in Chicago. Ann Intern Med 1998;129:173-81. (Pubitemid 28377506)
11. Hensel M, Volk T, Döcke WD, et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 1998;89:93-104. (Pubitemid 28319572)
12. Mimoz O, Benoist JF, Edouard AR, et al. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 1998;24:185-8. (Pubitemid 28190774)
13. Balcl C, Sungurtekin H, Gürses E, et al. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 2003;7:85-90. (Pubitemid 36204274)
14. Roberts WO. Exertional heat stroke:life-saving recognition and onsite treatment in athletic settings. Rev Bras Med Esporte 2005;11:329-32.
15. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29. (Pubitemid 15250137)
16. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.
17. Cervellin G, Comelli I, Lippi G. Rhabdomyolysis:historical background, clinical, diagnostic and therapeutic features. Clin Chem Lab Med 2010;48:749-56.
18. Calandra T, Cohen J; International Sepsis Forum Definition of Infection in the ICU Consensus Conference. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 2005;33:1538-48.
19. McGeer A, Campbell B, Emori TG, et al. Definitions of infection for surveillance in long-term care facilities. Am J Infect Control 1991;19:1-7.
20. Lu KC, Wang JY, Lin SH, et al. Role of circulating cytokines and chemokines in exertional heatstroke. Crit Care Med 2004;32:399-403.
21. Misset B, DeJonghe B, Bastuji-Garin S, et al. Mortality of patients with heatstroke admitted to intensive care units during the 2003 heat wave in France: a national multiple-center risk-factor study. Crit Care Med 2006;34:1087-92.
22. Bouchama A, Dehbi M, Mohamed G, et al. Prognostic factors in heat wave-related deaths. Arch Intern Med 2007;167:2170-6.
23. Argaud L, Ferry T, Le QH, et al. Short- and long-term outcomes of heatstroke following the 2003 heat wave in Lyon, France. Arch Intern Med 2007;167:2177-83.
24. Dhainaut JF, Claessens YE, Ginsburg C, et al. Unprecedented heat-related deaths during the 2003 heat wave in Paris: consequences on emergency departments. Crit Care 2004;8:1-2.
25. Baxter RE, Moore JH. Diagnosis and treatment of acute exertional rhabdomyolysis. J Orthop Sports Phys Ther 2003;33:104-8.
26. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994;79:1605-8.
27. Lambert GP, Gisolfi CV, Berg DJ, et al. Selected contribution: hyperthermia-induced intestinal permeability and the role of oxidative and nitrosative stress. J Appl Physiol 2002;92:1750-61; discussion 1749.
28. Bouchama A, Parhar RS, el-Yazigi A, et al. Endotoxemia and release of tumor necrosis factor and interleukin 1 alpha in acute heatstroke. J Appl Physiol 1991;70:2640-4.
29. Khan FY. Rhabdomyolysis:a review of the literature. Neth J Med 2009;67:272-83.
30. Martin C, Boisson C, Haccoun M, et al. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997;25:1813-19.
31. Haupt W, Fritzsche H, Hohenberger W, et al. Selective cytokine release induced by serum and separated plasma from septic patients. Eur J Surg 1996;162:769-76.
32. Pourakbari B, Setareh Mamishi S, Zafari J, et al. Evaluation of procalcitonin and neopterin level in serum of patients with acute bacterial infection. Braz J Infect Dis 2010;14:252-5.
33. Yousef AA, Amr YM, Suliman GA. The diagnostic value of serum leptin monitoring and its correlation with tumor necrosis factor-alpha in critically ill patients: a prospective observational study. Crit Care 2010;14:33-41.
34. Geppert A, Steiner A, Delle-Karth G, et al. Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock. Intensive Care Med 2003;29:1384-9.
35. Maruna P, Frasko R, Gürlich R. Plasma procalcitonin in patients with ileus. Relations to other inflammatory parameters. Physiol Res 2008;57:481-6.